ClinicalTrials.Veeva

Menu
V

Velocity Clinical Research | Greenville, SC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

AD504
Naltrexone Hydrochloride
Bupropion Hydrochloride
Atomoxetine Hydrochloride
Survodutide
BI 456906

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Enrolling
Obesity
Drug: Placebo
Drug: survodutide

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Enrolling
Obesity
Drug: Placebo
Drug: Naltrexone-Bupropion (NB) Combination

Trial sponsors

Apnimed logo
Boehringer Ingelheim logo
C
K

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems